Wahlstrom Mats 4
4 · TriSalus Life Sciences, Inc. · Filed May 15, 2026
Research Summary
AI-generated summary of this filing
TriSalus (TLSI) Director Mats Wahlstrom Receives RSU Awards
What Happened
Mats Wahlstrom, a director of TriSalus Life Sciences, was granted equity awards on May 14, 2026 totaling 147,032 shares (aggregate of three grants): 37,602 RSUs (F1), 34,226 retainer RSUs elected in lieu of cash fees (F2), and 75,204 derivative awards (listed as a derivative/option) (F5). All awards were granted at $0.00 per share (no cash paid) — this was a compensation grant, not an open-market purchase or sale.
Key Details
- Transaction date: May 14, 2026; Form 4 filed May 15, 2026 (filed promptly).
- Grants and amounts: 37,602 (RSU, F1); 34,226 (Retainer RSU, F2); 75,204 (derivative/option, F5). Total = 147,032 shares/units. Price reported: $0.00 per share.
- Vesting: F1 RSUs vest in full on the one‑year anniversary (May 14, 2027). F2 Retainer RSUs vest quarterly in equal one‑third installments through the remainder of 2026. F5 derivative/option vests in full on the one‑year anniversary (May 14, 2027).
- Ownership after transaction: not specified in the provided excerpt of the filing.
- Governance/beneficial‑ownership notes: Wahlstrom shares voting/investment discretion with his spouse regarding shares held by Leonard Capital LLC (F3) and is a managing member of HW Investment Partners, sharing discretion for HW Investment holdings (F4); he disclaims beneficial ownership except to the extent of any pecuniary interest.
- Transaction type code: A = Award/Grant; derivative line indicates an option or similar instrument. No indication of sales, purchases, or tax‑withholding in this filing.
Context
RSUs convert to company shares only once they vest, so these grants do not increase tradable shares immediately. The derivative/option award will similarly convert to shares only upon vesting/exercise per its schedule. Director compensation grants are routine corporate practice and, by themselves, do not necessarily signal a buy or sell opinion by the insider. Purchases (not present here) tend to carry more immediate informational value for investors.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-14+37,602→ 53,329 total - Award
Common Stock
[F2]2026-05-14+34,226→ 87,555 total - Award
Director Stock Option (right to buy)
[F5]2026-05-14+75,204→ 276,149 totalExercise: $2.52Exp: 2036-05-13→ Common Stock (75,204 underlying)
- 1,444,447(indirect: By LLC)
Common Stock
[F3] - 1,370,028(indirect: By LLC)
Common Stock
[F4]
Footnotes (5)
- [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.
- [F2]Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer.
- [F3]The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC.
- [F4]The Reporting Person is a managing member of HW Investment Partners, LLC ("HW Investment") and shares voting and investment discretion with respect to the shares held directly by HW Investment. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F5]The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.